Matthias Aizenberg

The landscape of therapeutic discovery is undergoing a seismic shift as artificial intelligence moves from being a mere digital assistant to becoming the very architecture upon which modern biology is built. Anthropic has recently solidified this transition by announcing the acquisition of

Ivan Kairatov is a leading biopharma expert with an extensive background in research and development, specializing in the intersection of biotechnology and advanced computational innovation. With a career dedicated to unraveling the complexities of the human genome and neurodegenerative

The biological machinery responsible for filtering waste sometimes malfunctions so catastrophically that routine metabolic processes turn into a source of systemic internal damage. Primary Hyperoxaluria represents a group of rare, inherited metabolic disorders that force the body into a state of

Modern precision engineering and medical diagnostics often struggle against the inherent tendency of light to scatter and lose focus as it moves through various environments. While traditional laser systems have revolutionized many industries, they remain shackled by the physical law of

The architecture of a malignant tumor is more than just a cluster of runaway cells; it is a sophisticated, oxygen-starved fortress designed to withstand the body’s most potent immune responses. For decades, oncologists have struggled to breach these "hypoxic" zones, where low oxygen levels trigger

Ivan Kairatov is a distinguished biopharmaceutical expert with a formidable track record in research and development, specifically focusing on the intersection of technological innovation and clinical strategy. With years of experience navigating the complexities of large-scale vaccine trials and

The biological mystery of why two women with the exact same genetic mutation face drastically different health outcomes remains one of the most pressing questions in modern oncology. While the presence of a BRCA1 mutation is often viewed as a definitive roadmap for a patient’s future, the actual

The rapid advancement of biotechnology across the African continent has created an urgent demand for a new generation of policy experts capable of managing complex biological risks while fostering scientific innovation. To meet this critical need, the School of Public Health’s Pandemic Center has

Ivan Kairatov stands at the intersection of biopharmaceutical innovation and clinical technology, bringing years of expertise in research and development to the forefront of oncology care. His work focuses on bridging the gap between raw medical data and actionable clinical insights, particularly

Physicians have long understood that the subtle dance of blood through a human heart cannot be captured by static imagery alone, yet the tools required to measure this flow have remained stubbornly invasive until now. For decades, the gold standard for diagnosing coronary obstructions involved